baber/WOPTO huggingface dataset:
Patent NZ-596221-A (NZ)
Title: A method for increasing the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure
Inventor: FRANK MARKUS
IPC: C05G3/60
Filed: 2010-05-03
Abstract: A method for increasing the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure, wherein the plants, the plant propagules, the seed of the plants and/or the locus where the plants are growing or are intended to grow are treated with an effective amount of a composition comprising a) the Bacillus subtilis strain with NRRL Accession No. B-21661 or a cell-free extract thereof, and/or a mutant of this strain or extract having all the identifying characteristics of the respective strain or extract as component (I), and b) optionally at least one chemical compound as component (II), selected from the active compound groups A) to J): A) strobilurins; B) carboxamides; C) azoles; D) heterocyclic compounds; E) carbamates; F) other active substances; G) growth regulators; H) herbicides; J) insecticides.
Patent NZ-597180-A (NZ)
Title: Analyzing patterns within transaction data
Inventor: GHOSH DEBASHIS
IPC: G06Q20/00
Filed: 2010-10-05
Abstract: A transaction data analyzer apparatus is associated with a financial entity and comprises (i) a user interface for allowing a user to provide inputs; (ii) a core transaction analyser and (iii) an output module for grouping results of an analysis. The core transaction analyser comprises a processor for analysing spatiotemporal trends in consumer transaction data and the analysis includes calculating a frequency of sequences of purchases made at merchants located within a maximum distance of one another.
Patent NZ-597241-A (NZ)
Title: Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor
Inventor: LIEPOLD BERND
IPC: A61K9/00
Filed: 2010-06-08
Abstract: IP No. 597241 The disclosure relates to a pharmaceutical dosage form which comprises a solid dispersion product comprising N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohex-1-en-1- yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1-((phenylsulfanyl)methyl) propyl)amino)-3-((trifluoromethyl)sulfonyl)benzenesulfonamide or a salt, hydrate or solvate thereof, at least one pharmaceutically acceptable polymer, and at least one pharmaceutically acceptable solubilizer. The disclosure is further directed to processes for preparing the pharmaceutical dosage form and to use of the dosage form for treating proliferative disorders.
Patent NZ-600262-A (NZ)
Title: Anti-her3 antibodies and uses thereof
Inventor: DIMOUDIS NIKOLAOS
IPC: A61K39/395
Filed: 2010-12-17
Abstract: 600262 Disclosed is an antibody which is binding to human HER3, characterized in that the heavy chain variable domain VH is SEQ ID NO:8 (containing CDR regions HRDYYSNSLTY, WIYAGTGSPSYNQKLQG and GYTFRSSYIS); and the light chain variable domain VL is SEQ ID NO:9, or the light chain variable domain VL is SEQ ID NO:10, or the light chain variable domain VL is SEQ ID NO:11(containing CDR regions QSDYSYPYT, WASTRES and either KSSQSLLNSGNQKNYLT or KSSQSVLNSGNQKNYL); or a humanized version thereof.
Patent NZ-608589-A (NZ)
Title: Solar energy capture and storage system with revenue recovery through energy sales
Inventor: ELLISTON BARBARA LOUISE
IPC: F24H1/00
Filed: 2012-03-23
Abstract: 608589 Disclosed is a solar energy capture and storage system (10). The system (10) includes one or more photovoltaic modules (11) and an inverter (12) electrically coupled to the photovoltaic modules (11). The inverter (12) converts DC generated by the photovoltaic modules (11) to AC, and outputs the AC with a time-averaged voltage that is variable between minimum and maximum levels. The inverter (12) works on a first mode, in which the inverter (12) is electrically isolated from a supply network and a second mode, in which the inverter (12) is coupled to the supply network. One or more heating elements (13) are electrically coupled either directly or indirectly to the output of the inverter (12). The outputting AC voltage level is variable to adjust the power outputted by the inverter (12) to the heating elements (13).
Patent NZ-617348-A (NZ)
Title: Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes
Inventor: KNOETGEN HENDRIK
IPC: C07K16/46
Filed: 2012-06-19
Abstract: Disclosed is a complex, characterized in that it comprises: - one fusion polypeptide that comprises in N- to C-terminal direction (i) a T-cell response eliciting peptide, (ii) a β2-microglobulin, and (iii) the extracellular domains α1, α2, and α3 of a class I MHC molecule, and - two polypeptide chains, which are linked by one or more disulfide bonds, wherein the first disulfide-linked polypeptide chain comprises in N- to C-terminal direction (i) an immunoglobulin light or heavy chain variable domain, (ii) an immunoglobulin light or heavy chain constant domain, and (iii) an antibody heavy chain hinge region polypeptide, and wherein the second disulfide-linked polypeptide chain comprises an antibody heavy chain hinge region polypeptide, wherein the fusion polypeptide is - covalently bound either to the C-terminus or the N-terminus of one of the disulfide-linked polypeptide chains, or - covalently bound to the N-terminus of an antibody variable domain that is the complementary heavy or light chain variable domain to that comprised in the first disulfide-linked polypeptide chain, or - covalently bound to the C-terminus of an antibody constant domain that is the complementary heavy or light chain constant domain to that comprised in the first disulfide-linked polypeptide chain with the proviso that the complex comprises exactly one fusion polypeptide.
Patent NZ-617979-A (NZ)
Title: Anti-theft devices and methods
Inventor: THEOBALD JAMES
IPC: H01R13/639
Filed: 2012-05-24
Abstract: An anti-theft device for securing an electronic product during retail display is disclosed. The electronic product has a socket for the transmission of power and/or information during normal operation of the electronic product. The anti-theft device comprises a plug (10) for engagement with the socket. The plug (10) has an insertable portion (14) for insertion into the socket. The insertable portion (14) has a locking configuration for locking it within the socket to prevent removal from the socket while in the locking configuration. The insertable portion (14) also has a release configuration for withdrawal from the socket. The plug (10) has a control mechanism for holding the insertable portion in the locking configuration such that when the plug (10) is engaged with the socket, the configuration of the insertable portion can be changed from the locking configuration to the release configuration by operation of the control mechanism by a security key. The anti-theft device also includes a flexible attachment for attaching the plug (10) to a fixture.
Patent NZ-621027-A (NZ)
Title: Footwear
Inventor: BRADLEY ANDREW MUNRO
IPC: A43C19/00
Filed: 2014-02-10
Abstract: 621027 Disclosed is a jandal, sandal, flip-flop, throng type footwear with strap plugs that resist pull-through and allow for easier replacement of broken straps. The footwear comprises a sole able to be located under the foot of a user, the sole having three holes passing through the sole and a front channel and first and second rear channels formed in an underside of the sole. The footwear also consists of a strap of unitary construction able to locate the sole under the foot of a user, the strap having three elongate plugs integrally formed with the strap; and wherein each of the three holes in the sole are aligned with respective channels so as to allow the three respective plugs to pass through each respective hole to be located in each of the respective channels to secure the strap to the sole. The three channels and the three plugs have complementary size and shape such that the three plugs are frictionally retained in the three channels. 6. The strap includes at least two side portions that are connected to the front plug and the respective rear plugs, and the two side portions join to form a central portion.
Patent NZ-625737-A (NZ)
Title: Pyrazolo[1,5-a]pyrimidines as antiviral agents
Inventor: BOOJAMRA CONSTANTINE G
IPC: C07D487/04
Filed: 2012-12-20
Abstract: Disclosed are compounds and pharmaceutically acceptable salts and esters and compositions thereof, for treating viral infections. The compounds and compositions are useful for treating Pneumovirinae virus infection including Human respiratory syncytial virus infections. The compounds have a pyrazolo[1,5-a]pyrimidines core.
Patent NZ-630282-A (NZ)
Title: Improvements in or in relation to vehicle suspensions
Inventor: RICHARD JAMES CLAMP
IPC: B60G99/00
Filed: 2014-09-05
Abstract: Upper and lower mounting adapters for conversion from coil to air suspension including various embodiments are described.
Patent NZ-713637-A (NZ)
Title: Improved method for seed priming
Inventor: SHEN TONGYUN
IPC: A01C1/02
Filed: 2013-04-29
Abstract: In prior methods, if seeds were saturated when contacted with water/fluid, the incubation time was strictly controlled to prevent seeds germination during priming. If the imbibitions were aborted before the seeds were saturated, especially the embryo which is usually situated inside the endosperm or pericarp, the priming effect was limited. Removing the seeds too early from imbibitions sometimes led to even poorer germination performance than seen in unprimed seeds. A method of seed priming is now provided in which the seed is allowed to become saturated with water during the immersion step and not requiring strict control of the subsequent incubation time, is provided. More particularly, the invention provides a method of seed priming comprising the steps of: providing a dry seed to be primed; immersing said seed into an aqueous solution; removing the seed from the aqueous solution once the seed has been saturated with water, wherein the immersion time at least is equal to the time required for the seed to enter the phase II of germination, but shorter than the time required for the seed to enter phase III of germination; reducing the water content of the seed by 1 to 10 wt.%; and incubating the seed under an atmosphere of air having a relative humidity of at least 95%, but less than 100%.
Patent NZ-716781-A (NZ)
Title: Nutritional composition having lipophilic compounds with improved solubility and bioavailability
Inventor: VURMA MUSTAFA
IPC: A61K31/593
Filed: 2014-08-28
Abstract: Disclosed herein is a nutritional composition having at least one protein, at least one fat, and at least one lipophilic compound, the composition comprising at least one assembly comprising at least one hydrophobic protein, monoglycerides and diglycerides (”MDG”) and at least one lipophilic compound, wherein at least 1% of the total MDG in the nutritional composition remains in the aqueous phase after centrifugation at 100,000 x g for 1 hour at 20 °C.
Patent NZ-717726-A (NZ)
Title: Anti-αβtcr antibody
Inventor: SNELL DANIEL
IPC: C07K16/28
Filed: 2012-09-12
Abstract: Disclosed is a humanised multispecific antibody comprising a first binding domain specific for the human αβTCR/CD3 complex and a second binding domain specific for a tumor-specific antigen, wherein the first binding domain comprises a heavy chain variable region having an amino acid sequence selected from the group consisting of the sequences set forth in SEQ ID NOs: 7, 12, 13, 15 and 16, and a light chain variable region comprising the amino acid sequence set forth as SEQ ID NO: 14.
Patent NZ-719643-A (NZ)
Title: Dry formulations of vaccines that are room temperature stable
Inventor: QIAO ZHISONG
IPC: C12N7/00
Filed: 2014-09-11
Abstract: A dry formulation of a vaccine comprises a live attenuated virus, 30% to 80% (w/w) of a non-reducing oligosaccharide, 5% to 40% (w/w) of an amino acid stabilizer, 2% to 20% (w/w) of a protein stabilizer, and a buffer having a pH of 6.0 to 8.0. The amino acid stabilizer is arginine; and wherein said dry formulation is prepared as a cake, prepared on a membrane or filter, dried as a powder, by freeze-drying in beads, by spray drying, or by spray freeze drying. A method of vaccinating a non-human animal against a virus selected from the group consisting of distemper virus, adenovirus, parainfluenza virus, parvovirus, and any combination thereof, comprising mixing the above described dry formulation with a pharmaceutically acceptable carrier to form a liquid vaccine and then administering the liquid vaccine to the non-human animal. A vaccine comprises the above described dry formulation combined with a dry formulation comprising a live attenuated parvovirus, 10% to 80% (w/w) of a sugar alcohol, 10% to 70% (w/w) of a bulking stabilizer, 4% to 50% (w/w) of a protein stabilizer, a buffer having a pH of 6.8 to 8.0 and a liquid pharmaceutically acceptable carrier.
Patent NZ-724913-A (NZ)
Title: Portable industrial air filtration device
Inventor: GRIDER KEITH
IPC: B01D46/46
Filed: 2014-03-12
Abstract: Various embodiments of the present disclosure provide a portable industrial air filtration device employing an annular dual filter assembly to capture and remove impurities from the air surrounding the air filtration device, enabling the air filtration device to quickly and efficiently improve the quality and safety of the air. The air filtration device includes a two-piece housing including a lower housing component and a locking cover removably attachable to the lower housing component. The dual filter assembly is mounted within the housing between the locking cover and the lower housing component, and includes a removable self-supporting outer pre-filter surrounding a separately removable inner HEPA filter. The pre-filter initially filters the surrounding air by capturing relatively large or coarse impurities, and the HEPA filter further filters the air pulled through the pre-filter by capturing relatively small or fine impurities.
Patent NZ-727773-A (NZ)
Title: Metal-catalyzed asymmetric 1,4-conjugate addition of vinylboron compounds to 2-substituted-4-oxy- cyclopent-2-en-1-ones yielding prostaglandins and prostaglandin analogs
Inventor: WU PING-YU
IPC: C07C45/61
Filed: 2015-07-09
Abstract: This invention provides a novel method for the preparation of 2,3- disubstituted-4-oxy-cyclopentan-l-one compounds that are useful for the synthesis of prostaglandins and prostaglandin analogs of industrial relevance. The method comprises the metal -catalyzed asymmetric 1,4-conjugate addition of vinylboron compounds to 2- substituted-4-oxy-cyclopent-2-en-l-ones. This method relies on the use of less toxic, easily- handled reagents, and can be performed under milder conditions than offered by some conventional methods, affording 2,3-disubstituted-4-oxy-cyclopentan-l-one compounds enantio- and diastereoselectively, which are precursors to the said prostaglandin and prostaglandin analogs, in high yield.
Patent NZ-750885-A (NZ)
Title: Blood plasma fractions as a treatment for aging-associated cognitive disorders
Inventor: NIKOLICH KAROLY
IPC: A61P25/28
Filed: 2017-04-27
Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as neurocognitive disorders.
Patent NZ-766778-A (NZ)
Title: Nasal assembly
Inventor: GUNEY MEMDUH
IPC: A61M16/06
Filed: 2004-02-20
Abstract: A nasal assembly (10) for delivering breathable gas to a patient includes a frame (16) having an integrally formed first connector portion (24). A nozzle assembly (18) includes a gusset or base portion (48) and a pair of nozzles (50). At least one inlet conduit is structured to deliver breathable gas into the frame and nozzle assembly for breathing by the patient. A pair of second connector portions (26) are removably and rotatably connected to respective first connector portions of the frame and are in communication with respective inlet conduits, e.g., directly or via angle connectors. A headgear assembly (20) is removably connected to the pair of second connector portions and/or the angle connectors so as to maintain the frame and the nozzle assembly in a desired adjusted position on the patient’s face.
Patent PT-109395-A (PT)
Title: Composições veterinárias orais parasiticidas compreendendo agentes activos de actuação sistémica, métodos e as suas utilizações
Inventor: SUSAN MANCINI CADY
IPC: A61K31/194
Filed: 2013-01-31
Abstract: ESTA INVENÇÃO REFERE-SE A COMPOSIÇÕES VETERINÁRIAS ORAIS PARA COMBATER ECTOPARASITAS E ENDOPARASITAS EM ANIMAIS, COMPREENDENDO PELO MENOS UM AGENTE ACTIVO DE AC-TUAÇÃO SISTÉMICA EM ASSOCIAÇÃO COM UM VEÍCULO FARMACEUTICAMENTE ACEITÁVEL. ESTA INVENÇÃO TAMBÉM PROPORCIONA MÉTODOS MELHORADOS PARA A ERRADICAÇÃO, CONTROLO E PREVENÇÃO DE INFECÇÕES E INFESTAÇÕES PARASITÁRIAS NUM ANIMAL COMPREENDENDO A ADMINISTRAÇÃO DAS COMPOSIÇÕES DA INVENÇÃO AO ANIMAL DELAS NECESSITADO.
Patent PT-109618-A (PT)
Title: Método para gestão de risco ao longo do ciclo de vida de produtos e processos complexos
Inventor: TIAGO M ROBALO
IPC: G06Q50/22
Filed: 2016-09-14
Abstract: MÉTODO PARA A CONSTRUÇÃO DE WORKFLOWS PARA GESTÃO DE RISCO ('PASSO A'), COMPREENDENDO DIVERSAS FERRAMENTAS DE IDENTIFICAÇÃO, ANÁLISE E CONTROLO DE RISCO TOTALMENTE INTEGRADAS E SEM DESCONTINUIDADES ('PASSO B'), PARA APLICAÇÃO NA CONCEPÇÃO E PROJECTO DE PROCESSOS, QUALIFICAÇÃO DE PROCESSOS E EQUIPAMENTOS, GESTÃO DAS FASES DE PRODUÇÃO E ABASTECIMENTO ('PASSO C') NO PROCESSAMENTO EM MÚLTIPLAS ETAPAS DE PRODUTOS QUÍMICOS, FARMACÊUTICOS OU BIOLÓGICOS ('PASSO D'), PARA IDENTIFICAÇÃO, AVALIAÇÃO, MITIGAÇÃO E GESTÃO DE RISCOS SOBRE A QUALIDADE, SEGURANÇA OU EFICÁCIA DAQUELES PRODUTOS AO LONGO DO SEU CICLO DE VIDA ('PASSO E') E, NESTE CONTEXTO, DANDO SUPORTE À VERIFICAÇÃO CONTINUADA DO PROCESSO, ÀS AVALIAÇÕES PERIÓDICAS DE QUALIDADE DO PRODUTO, E À MELHORIA CONTÍNUA BASEADAS-EM CONHECIMENTO DO PROCESSO E DO PRODUTO ('PASSO F'). OS WORKFLOWS ('PASSO A') PODEM SER ESPECÍFICOS DE DETERMINADAS FASES ('PASSO C'), PRODUTOS ('PASSO D'), EQUIPAMENTO DE PRODUÇÃO OU INSTALAÇÕES UTILIZADAS NO FABRICO DE PRODUTOS, PODENDO E DEVENDO SER COMBINADOS DE MODO A APOIAR A GESTÃO DO CICLO DE VIDA DOS PASSOS 'E' E 'F'. O USO DE WORKFLOWS ('PASSO A') COMBINADOS COM AS FERRAMENTAS DO 'PASSO B' APOIA O TIPO DE ATIVIDADES MENCIONADAS NOS PASSOS 'E' E 'F', FORNECE UMA ESTRUTURA PARA GESTÃO DO CONHECIMENTO ('PASSO F') APLICÁVEL A MÚLTIPLOS PRODUTOS E TECNOLOGIAS, QUE, POR SUA VEZ, SUPORTA UMA JUSTIFICAÇÃO COM BASE CIENTÍFICA PARA A TOMADA DE DECISÕES EM DETERMINADAS ETAPAS DO CICLO DE VIDA ('PASSO C').
Patent RU-94025711-A (RU)
Inventor: JUDIN JA B
IPC: A61B17/00
Filed: 1994-07-08
Abstract: FIELD: medicine; pediatrics. SUBSTANCE: method involves isolation and cutting off the distal part of the round ligament of the liver, unfolding the ligament and suturing it to the lesser curvature of stomach. Such fixation helps cure gastroptosis while preserving the physiological mobility of the stomach. EFFECT: higher efficacy.
Patent RU-94028972-A (RU)
Inventor: ZHITOMIRSKIJ G A
IPC: G02F1/00
Filed: 1994-08-02
Abstract: FIELD: adaptive optical systems. SUBSTANCE: phase modulator has deformed mirror 1, stiff base 2, and piezoids 3 made in the form of rods of cross-shaped transverse section and trapezoidal longitudinal section. Width and height of rod transverse section at its joint with mirror are equal and their sum at its joint with base does not exceed double distance between center lines of adjacent piezoids. The latter are spaced 90 deg apart. Gate electrodes 4 are deposited on side surfaces of rod. EFFECT: increased deformation and extended range of adaptive mirror operating frequencies enabling use of device in adaptive optical information systems of infra-red range. 3 dwg
Patent RU-94029222-A (RU)
Inventor: BARSOV A L
IPC: C25C3/12
Filed: 1994-08-04
Abstract: FIELD: metallurgy, production of aluminium by electrolytic method in electrolyzers with anode burnt in advance. SUBSTANCE: holder has aluminium rod and steel bracket with groove joined by welding through bimetal plates put into groove. Bimetal plates are so positioned in groove that contact surfaces of joining of heterogeneous materials form angle not exceeding 10 deg with vertical line. EFFECT: increased operational resistance, reduced energy consumption.
Patent RU-94030133-A (RU)
Inventor: ERMOLAEV A M
IPC: E21F1/06
Filed: 1994-08-10
Abstract: FIELD: mining. SUBSTANCE: joint has links of pipes to be joined. The links are provided with locking rings between which a detachable distance ring is interposed. The ring is made up as a one-turn plate torsion spring. The radius of curvature of the spring varies. A locking pin is secured at one of the ends of the spring from outside. A through groove for holding the spring in a compressed state is provided at the other end of the spring. In accordance to the second version, linings are rigidly secured on the outer side of one end and inner side of the other end of the spring. The working surfaces of the linings are inclined. EFFECT: enhanced reliability. 5 cl, 4 dwg
Patent RU-94030216-A (RU)
Inventor: MIKHAJLOVA E M
IPC: A61K36/752
Filed: 1994-08-08
Abstract: FIELD: medicine; particularly, nonpharmacologic remedies for treating inflammatory processes connected with avitaminosis and dystrophy affected tissues, and mainly, for treating parodontosis. SUBSTANCE: mixture contains ingredients in the following ratio, wt.-%: aloe juice, 5-20; beehoney, 20-40; lemon juice, 5-20; ground kernels of walnut, 25-40. EFFECT: increased treating effect.
Patent RU-94033303-A (RU)
Inventor: SHERMERGORN I M
IPC: C23F11/08
Filed: 1994-09-14
Abstract: FIELD: means for protection of oil field equipment from corrosion in mineralized aqueous media; applicable in oil producing industry. SUBSTANCE: corrosion inhibitor contains product of reaction of oxyethylated fatty alcohol or oxyethylated alkyl phenol, phosphorous acid and ethanol amine of basic formula HN(CHOH), where n=1,2,3 taken in molar ratio of 1:(0.8-1.2): (0.8-1.2), respectively. Preferred version of the corrosion inhibitor contains reaction product indicated above and solvent in the following amount of components, mas.%: above-indicated reaction product 20-80; the balance, solvent. EFFECT: higher protective effect from hydrogen sulfide and oxygen corrosion.
Patent RU-94036385-A (RU)
Inventor: POLISHCHUK B O
IPC: C08L1/12
Filed: 1994-09-28
Abstract: FIELD: chemical industry, production of solutions for films formation on base of cellulose esters in particular and in production of manufactured fibrous and film materials. SUBSTANCE: solution allows to increase light- and heat-resistance of film cellulose triacetate due to the fact, that solution for formation has 8-10 mas % of polymer, 0.01-0.024 mass % of 1- [1'-methylbenzimidazolyl-2'] -3-methyl-5-[2'-(n-sulfamidophenyl)-5" -ethyl-3", 4"-thiodiazolyl] formazan and up to 100 mass % of mixture of methylenechloride with ethanol in volumetric ratio of 9 : 1. EFFECT: increased light- and thermo-resistance of films of cellulose triacetate. 1 tbl